Novavax Vaccine’s Phase 3 Win Is Sending NVAX Stock to $350 - Investorplace.com

1. Novavax Vaccine’s Phase 3 Win Is Sending NVAX Stock to $350  Investorplace.com
2. J&J says its one-shot Covid-19 vaccine is 72% effective in the U.S.  CNBC Television
3. Novavax’s Vaccine Works Well — Except on Variant First Found in South Africa  The New York Times
4. Covid-19: Novavax vaccine shows 89% efficacy in UK trials @BBC News live - BBC  BBC
5. Look Out, Pfizer and Moderna: Here Comes Novavax  Motley Fool
6. View Full Coverage on Google News

Source: https://ift.tt/3taFe3C